Effector-mediated subversion of proteasome activator (PA)28αβ enhances host defense against Legionella pneumophila under inflammatory and oxidative stress conditions
PLOS Pathogens · 22.06.2023 · 19 (6) · e1011473
DOI: 10.1371/journal.ppat.1011473 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 22.06.2023. Verfasst von Tshegofatso Ngwaga und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology, Kansas State University, Manhattan, Kansas, United States of America. Hauptthemen laut MEDLINE: Legionella pneumophila, Legionnaires' Disease, Amoeba. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, Johnson Cancer Research Center, Kansas State University.
Abstract (Originalsprache)
Legionella pneumophila is a natural pathogen of amoebae that causes Legionnaires’ Disease in immunocompromised individuals via replication within macrophages. L . pneumophila virulence and intracellular replication hinges on hundreds of Dot/Icm-translocated effector proteins, which are essential for biogenesis of the replication-permissive Legionella -containing vacuole (LCV). However, effector activity can also enhance mammalian host defense via effector-triggered immunity. The L . pneumophila effector LegC4 is important for virulence in amoebae but enhances host defense against L . pneumophila in the mouse lung and, uniquely, within macrophages activated with either tumor necrosis factor (TNF) or interferon (IFN)-γ. The mechanism by which LegC4 potentiates cytokine-mediated host defense in macrophages is unknown. Here, we found that LegC4 enhances cytokine-mediated phagolysosomal fusion with Legionella -containing vacuole (LCV) and binds host proteasome activator (PA)28α, which forms a heterooligomer with PA28β to facilitate ubiquitin-independent proteasomal degradation of oxidant-damaged (carbonylated) proteins. We found that oxidative stress was sustained in the presence of LegC4 and that the LegC4 restriction phenotype was relieved in PA28αβ-deficient macrophages and in the lungs of mice in vivo . Our data also show that oxidative stress is sufficient for LegC4-mediated restriction in macrophages producing PA28αβ. PA28αβ has been traditionally associated with antigen presentation; however, our data support a novel mechanism whereby effector-mediated subversion of PA28αβ enhances cell-autonomous host defense against L . pneumophila under inflammatory and oxidative stress conditions. This work provides a solid foundation to evaluate induced proteasome regulators as mediators of innate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biology, Kansas State University, Manhattan, Kansas, United States of America.
- Department of Microbiology & Molecular Genetics, Michigan State University, East Lansing, Michigan, United States of America.
ORCID-Profile: Stephanie R Shames
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- Johnson Cancer Research Center, Kansas State University
- Kansas-INBRE
- Michigan State University
- Kansas State University
Zitieren
APA
Ngwaga, T., Chauhan, D., Salberg, A. G., & Shames, S. R. (2023). Effector-mediated subversion of proteasome activator (PA)28αβ enhances host defense against Legionella pneumophila under inflammatory and oxidative stress conditions. PLOS Pathogens, 19(6), e1011473. https://doi.org/10.1371/journal.ppat.1011473
Vancouver
Ngwaga T, Chauhan D, Salberg AG, Shames SR. Effector-mediated subversion of proteasome activator (PA)28αβ enhances host defense against Legionella pneumophila under inflammatory and oxidative stress conditions. PLOS Pathogens. 2023;19(6):e1011473. doi:10.1371/journal.ppat.1011473
BibTeX
@article{Ngwaga2023,
author = {Ngwaga, Tshegofatso and Chauhan, Deepika and Salberg, Abigail G and Shames, Stephanie R},
title = {Effector-mediated subversion of proteasome activator (PA)28αβ enhances host defense against Legionella pneumophila under inflammatory and oxidative stress conditions},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {6},
pages = {e1011473},
doi = {10.1371/journal.ppat.1011473}
}
EUVIMED